United States Securities and Exchange Commission · EDGAR Accession 0001665160-25-001346

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-35542
Issuer CIK 2045356
Raising via StartEngine Primary, LLC

Ignite Biomedical, Inc.

CorporationDEIncorporated 2022FRAMINGHAM, MAignitebiomedical.com
Progress updateAt the close of the offering, the Issuer closed on $168,072.81.
A

The Offering

as disclosed in this filing
Other (Convertible Note)
$20,000
$1,235,000
July 28, 2025
Expired 321 days ago
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasingDebt / assets 1226%2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(2,513,567)(1,548,172)▼ burn
Total assets249,693725,006▼ 66%
Cash & equivalents233,657725,006▼ 68%
Accounts receivable00
Short-term debt1,235,394525,150▲ 135%
Long-term debt1,825,0001,500,000▲ 22%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-35542 · all filings under this campaign
Loading campaign history…